In short
Chloroquine phosphate has a long history in medicine, primarily known for its use in treating malaria. However, recent clinical trials have been exploring its potential applications in a wider range of conditions. This article examines how chloroquine phosphate is being used in various clinical trials, from its traditional role in malaria treatment to emerging applications in conditions such as COVID-19, autoimmune diseases, and even cancer. By reviewing current research, we can better understand the versatility of this medication and its potential benefits and limitations across different medical contexts.
Key points
- Chloroquine phosphate, traditionally used for treating malaria, is being investigated for a range of medical applications beyond its original purpose. Clinical trials are exploring its potential in treating COVID-19 infections, where it may inhibit viral entry into cells, though results remain inconclusive. For malaria, particularly Plasmodium vivax infections, it remains effective in many regions when administered in a standard three-day regimen, often combined with primaquine to prevent relapses. The drug's anti-inflammatory properties make it valuable for autoimmune conditions like hepatitis, while its effects on cellular processes have prompted studies in cancer treatment combinations and cardiovascular conditions such as atrial fibrillation. Research is also examining chloroquine's role in modulating immune responses in HIV patients and its preventive potential against infectious diseases.
What is chloroquine phosphate?
Chloroquine phosphate is a medication that has been used for over 70 years in various medical applications. It belongs to the class of drugs known as 4-aminoquinolines, which are synthetic derivatives of quinine, a compound originally extracted from the bark of the Cinchona tree . Chloroquine is available in tablet form, with each tablet typically containing 250 mg of chloroquine phosphate (equivalent to 150 mg of chloroquine base).
Common brand names for chloroquine phosphate include Aralen, Chloroquine, and Plasmodín. In some regions, the drug may also be known as Chloroquine diphosphate or A-CQ .
Medical Uses
Chloroquine phosphate has several established medical uses, with the most significant applications including:
Malaria Treatment and Prevention
Chloroquine has been widely used since 1946 for both treatment and prevention (prophylaxis) of malaria . It is particularly effective against certain types of the malaria parasite, including:
- Plasmodium vivax
- Plasmodium malariae
- Plasmodium ovale
- Susceptible strains of Plasmodium falciparum
For uncomplicated malaria, chloroquine is typically administered as a 3-day regimen with a total dose of 25 mg/kg body weight . However, due to increasing resistance of Plasmodium falciparum to chloroquine in many parts of the world, its use has been limited in regions where resistant strains are common.
Autoimmune Diseases
Chloroquine has anti-inflammatory properties that make it useful in treating certain autoimmune conditions , including:
- Autoimmune hepatitis
- Systemic lupus erythematosus
- Rheumatoid arthritis
In these conditions, chloroquine helps reduce inflammation and modify the immune system's response. For autoimmune hepatitis, studies have shown that chloroquine can help maintain remission after withdrawal of standard treatments .
Other Medical Uses
Research has explored additional applications for chloroquine, including:
- Treatment of viral infections
- Atrial fibrillation management
- Cancer therapy adjuvant
How Chloroquine Works
Chloroquine's mechanisms of action vary depending on the condition being treated:
Antimalarial Action
As an antimalarial agent, chloroquine:
- Accumulates in the acidic food vacuoles of malaria parasites
- Increases the pH within these vacuoles
- Interferes with the parasite's ability to digest hemoglobin
- Disrupts the parasite's metabolism and reproduction
Anti-inflammatory and Immunomodulatory Effects
In autoimmune conditions, chloroquine:
- Inhibits the release of tumor necrosis factor (TNF) from mononuclear phagocytes
- Down-regulates TNF receptors by delaying their transport to the cell surface
- Alters membrane permeability and lysosomal function
- Accumulates in tissues in considerable amounts (200-700 times the plasma concentration can be found in liver, spleen, kidneys, and lungs)
Dosage and Administration
Chloroquine dosage varies significantly based on the condition being treated, the patient's weight, and other factors. Always follow your healthcare provider's specific instructions.
For Malaria Treatment
The standard adult dosage for treating uncomplicated malaria is typically:
- Day 1: 10 mg/kg body weight (usually 4 tablets for adults)
- Day 2: 10 mg/kg body weight (4 tablets)
- Day 3: 5 mg/kg body weight (2 tablets)
For children or adults under 60 kg, the dosage is adjusted based on weight.
For Malaria Prevention
For prophylaxis (prevention) in areas with chloroquine-sensitive malaria:
- Adults: 500 mg (300 mg base) once weekly
- Start 1-2 weeks before travel to endemic areas
- Continue during travel and for 4 weeks after leaving the area
For Autoimmune Conditions
For conditions like autoimmune hepatitis:
- Typical dose is 250 mg daily
- Treatment duration depends on the specific condition and response
Side Effects and Safety Concerns
While chloroquine is generally considered safe when used as directed, it can cause various side effects ranging from mild to severe.
Common Side Effects
Mild and transient side effects may include:
- Gastrointestinal symptoms (nausea, vomiting, diarrhea)
- Headache
- Dizziness
- Blurry vision
- Fatigue
Serious Side Effects
More severe reactions that require immediate medical attention include:
- Eye injuries (retinopathy, changes to the retina, lens, cornea, or optic nerve)
- Cardiovascular manifestations (heart rhythm abnormalities)
- Neuromuscular disorders
- Hearing loss
- Severe skin reactions
Ocular Toxicity
One of the most concerning adverse effects of chloroquine is retinal damage, which can occur with long-term use. This risk increases with:
- Higher daily doses (exceeding 250 mg of chloroquine phosphate)
- Longer duration of treatment
- Pre-existing eye conditions
- Kidney or liver disease
To minimize this risk, regular ophthalmologic examinations (every 4-6 months) are recommended for patients on long-term chloroquine therapy.
QT Interval Prolongation
Chloroquine can prolong the QT interval on electrocardiogram (ECG), potentially leading to serious cardiac arrhythmias. This risk is higher in patients with:
- Pre-existing heart conditions
- Electrolyte imbalances
- Concurrent use of other QT-prolonging medications
Drug Interactions
Chloroquine can interact with various medications, potentially increasing the risk of side effects or reducing effectiveness.
Significant Interactions
- Antacids and kaolin: May reduce absorption of chloroquine
- Ampicillin: Chloroquine may reduce its absorption
- Cyclosporine: Chloroquine may increase blood levels
- Digoxin: Chloroquine may increase digoxin levels
- QT-prolonging drugs: Increased risk of cardiac arrhythmias
- Mefloquine: Increased risk of seizures
Special Populations
Pregnancy and Breastfeeding
Chloroquine is considered relatively safe during pregnancy, particularly for malaria treatment and prevention. It has been widely used for decades in pregnant women with no evidence of significant harm to the fetus . Chloroquine is also considered safe during breastfeeding, as the amount excreted in breast milk is not sufficient to harm the infant.
G6PD Deficiency
Unlike primaquine, chloroquine is generally considered safe for patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency. In fact, chloroquine is often used as an alternative treatment in these patients when primaquine is contraindicated .
Children
Chloroquine can be used in children, with dosage adjusted based on weight. However, children may be more sensitive to chloroquine toxicity, so careful dosing is essential .
Elderly
Older adults may be more sensitive to the effects of chloroquine and may require dosage adjustments. They are also at higher risk for side effects, particularly retinal toxicity and cardiac effects .
COVID-19 Research
During the COVID-19 pandemic, chloroquine was investigated as a potential treatment for SARS-CoV-2 infection. Early laboratory studies suggested that chloroquine might inhibit virus entry into cells and reduce viral replication .
Several clinical trials were conducted to evaluate the efficacy and safety of chloroquine in COVID-19 patients, including:
- A multi-center, randomized, open-label trial in Vietnam to evaluate the safety and efficacy of chloroquine in hospitalized adults with confirmed SARS-CoV-2 infection
- A trial in Poland examining chloroquine's potential role in reducing COVID-19-related hospitalization or death in ambulatory patients
- Studies evaluating chloroquine as prophylaxis for healthcare workers exposed to COVID-19 patients
However, subsequent larger clinical trials did not demonstrate significant benefits for COVID-19 treatment, and concerns about potential cardiac toxicity led most medical authorities to recommend against its use for this indication outside of clinical trials .
Current Research and Future Applications
Research continues to explore new potential applications for chloroquine:
Cancer Treatment
Studies are investigating chloroquine's potential as an adjunct to cancer therapy. It may enhance the effectiveness of certain chemotherapy drugs by inhibiting autophagy (a cellular process that cancer cells can use to survive treatment) .
Atrial Fibrillation
Early research is examining whether chloroquine could help terminate persistent atrial fibrillation, potentially offering a new pharmacological approach to managing this common heart rhythm disorder .
HIV Infection
Some studies have explored chloroquine's ability to modulate T-cell immune activation in HIV-infected individuals. It may help improve CD4 T-cell recovery in patients receiving antiretroviral therapy .
Influenza Prevention
Research has evaluated chloroquine's potential for preventing influenza infection, though results have been mixed .
As with any medication, it's important to use chloroquine only as prescribed by your healthcare provider. Regular monitoring is essential, particularly for patients on long-term therapy, to detect and manage potential side effects early.